Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 16 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

13%

2 trials in Phase 3/4

Results Transparency

0%

0 of 15 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
11(73.3%)
Phase 3
2(13.3%)
Phase 2
2(13.3%)
15Total
N/A(11)
Phase 3(2)
Phase 2(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (16)

Showing 16 of 16 trials
NCT03950752Not ApplicableCompleted

Effect of Consumption of Bagel Without Palm Oil on Postprandial Lipidemia

Role: lead

NCT03630588Phase 2Completed

Effect of the Consumption of an Enriched Surimi in Abdominal Visceral Adiposity

Role: lead

NCT04641559Not ApplicableCompleted

Personalized Nutrition Advice for Optimizing Dietary Habits and Metabolic Status

Role: lead

NCT03202901Not ApplicableCompleted

Accute Effect of B-Turmactive Both on Mild and Moderate Knee Pain on Healthy Volunteers

Role: lead

NCT04141059Not ApplicableCompleted

Effect of Oligopin® on Skin Ageing

Role: lead

NCT03946553Completed

The Dysbiosis of the Intestinal Microbiota in Individuals With Allergic Rhinitis (MICRORIN)

Role: lead

NCT04234100Not ApplicableCompleted

Bioavailability of Hesperidine and Narirutin From Orange Juice to Identify Metabotypes in Hypertension

Role: lead

NCT04010565Not ApplicableCompleted

Effect of a Black Garlic Extract on Cholesterol LDL Levels

Role: lead

NCT02479568Phase 3Completed

Beneficial Impact of Orange Juice Consumption on Risk Factors Associated With Cardiovascular Diseases

Role: lead

NCT02063477Not ApplicableCompleted

Effect of Oligopin® on Blood Pressure.

Role: lead

NCT03951025Phase 2Completed

Study of the Bioavailability of a Food Supplement Rich in Melatonin Administered Sublingually and Orally (MELATONIN)

Role: lead

NCT03984916Not ApplicableCompleted

Study of the Bioavailability of Three Hesperidin Extracts.

Role: lead

NCT03108508Not ApplicableCompleted

Non-inferiority Bioavailabilty Study of 3 Silicon-rich Supplements

Role: lead

NCT02628353Phase 3Unknown

Effect of a Specific Phenolic Compound on Blood Pressure

Role: lead

NCT01681394Not ApplicableCompleted

Effect of a Polyphenol-rich Cocoa Extract on Peripheral Blood Mononuclear Cells Gene Expression

Role: lead

NCT01688154Not ApplicableCompleted

Ability of Grape Seed Proanthocyanidins to Reduce Postprandial Triglycerides in Humans

Role: lead

All 16 trials loaded